Tumor characteristics such as immunohistochemistry (IHC), expression of steroid receptors, and human epidermal growth factor receptor 2 (HER2) status are highly specific for predicting axillary lymph node metastasis, though their prognostic impact has not been widely established9. Here, ERBB2 is linked to metastatic malignant neoplasm in the lymph nodes.